Feb 17, 2021 | 340B, Litigation, News and Updates
A district court judge in California today dismissed a lawsuit filed by several hospital associations seeking to ensure enforcement of 340B discounts when drugs are dispensed through contract pharmacies. The judge concluded that the lawsuit was premature, as no final...
Dec 30, 2020 | 340B, News and Updates
Following a series of disputes between drug manufacturers and participants in the 340B program over contract pharmacies, on December 30, 2020, the Health and Resource Service Administration (HRSA) issued Advisory Opinion 20-06, concluding that the plain meaning of the...
Dec 14, 2020 | 340B, News and Updates, Rulemaking
On December 14, 2020, the Health and Resource Service Administration (HRSA) published a Final Rule specifying the requirements and procedures for the 340B Program’s administrative dispute resolution (ADR) process. The process was established to support covered...
Dec 11, 2020 | 340B, Litigation, News and Updates
Six national associations representing hospitals and pharmacists, and three individual hospitals participating in the 340B drug discount program, filed a lawsuit in the Northern District of California asking the court to order the Health and Resource Service...
Mar 23, 2020 | 340B, News and Updates
In March 2020, the Health Resources and Services Administration published a set of frequently asked questions (FAQs) for 340B stakeholders related to the COVID-19 pandemic. The FAQs address certain flexibilities and exemptions available to covered entities during the...
Jan 30, 2020 | 340B, Litigation, News and Updates
After the Health and Resource Service Administration (HRSA) issued a December Advisory Opinion requiring 340B discounts for drugs dispensed through contract pharmacies, four drug manufacturers—Eli Lilly, AstraZeneca, Sanofi, and Novo Nordisk—have now filed four...
